Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Measles-rubella and Rotavirus Vaccines in Infants
NCT01700621Phase 4Completed
- Sponsor
- PATH
- Start
- Jan 2013
- Primary completion
- Sep 2013
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rotavirus vaccine, live, oral in measles, rubella and rotavirus infection, sponsored by PATH. Primary endpoint: Percentage of Subjects With Seroprotection for Measles Virus Serum Neutralization Antibodies. Started Jan 2013; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
measlesrubellarotavirus infection
Beyond the preview
Go deeper on NCT01700621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01700621.